These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 31144773)

  • 41. Functional variation in the gut microbiome of wild Drosophila populations.
    Bost A; Martinson VG; Franzenburg S; Adair KL; Albasi A; Wells MT; Douglas AE
    Mol Ecol; 2018 Jul; 27(13):2834-2845. PubMed ID: 29802796
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Recent Advancements in Intestinal Microbiota Analyses: A Review for Non-Microbiologists.
    Feng XW; Ding WP; Xiong LY; Guo L; Sun JM; Xiao P
    Curr Med Sci; 2018 Dec; 38(6):949-961. PubMed ID: 30536055
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Amphibian gut microbiota shifts differentially in community structure but converges on habitat-specific predicted functions.
    Bletz MC; Goedbloed DJ; Sanchez E; Reinhardt T; Tebbe CC; Bhuju S; Geffers R; Jarek M; Vences M; Steinfartz S
    Nat Commun; 2016 Dec; 7():13699. PubMed ID: 27976718
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The human gut microbiome as source of innovation for health: Which physiological and therapeutic outcomes could we expect?
    Doré J; Multon MC; Béhier JM;
    Therapie; 2017 Feb; 72(1):21-38. PubMed ID: 28131442
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Specific features of the enteric microbiota composition in patients with alcoholic liver cirrhosis].
    Shalikiani NV; Bakulin IG; Dubinkina VB; Ishchenko DS; Alexeev DG; Tyakht AV; Pavlenko AV; Ilyina EN; Kostryukova ES; Taraskina AE; Skorodumova LO; Maev IV; Govorun VM
    Ter Arkh; 2015; 87(12):59-65. PubMed ID: 26978420
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Predictive metabolomic profiling of microbial communities using amplicon or metagenomic sequences.
    Mallick H; Franzosa EA; Mclver LJ; Banerjee S; Sirota-Madi A; Kostic AD; Clish CB; Vlamakis H; Xavier RJ; Huttenhower C
    Nat Commun; 2019 Jul; 10(1):3136. PubMed ID: 31316056
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Genome-resolved metaproteomic characterization of preterm infant gut microbiota development reveals species-specific metabolic shifts and variabilities during early life.
    Xiong W; Brown CT; Morowitz MJ; Banfield JF; Hettich RL
    Microbiome; 2017 Jul; 5(1):72. PubMed ID: 28693612
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Strategizing the human microbiome for small molecules: Approaches and perspectives.
    Hussain A; Patwekar U; Mongad DS; Shouche YS
    Drug Discov Today; 2023 Feb; 28(2):103459. PubMed ID: 36435302
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Oral Administration of Porphyromonas gingivalis Alters the Gut Microbiome and Serum Metabolome.
    Kato T; Yamazaki K; Nakajima M; Date Y; Kikuchi J; Hase K; Ohno H; Yamazaki K
    mSphere; 2018 Oct; 3(5):. PubMed ID: 30333180
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Metabolic Modeling of Human Gut Microbiota on a Genome Scale: An Overview.
    Sen P; Orešič M
    Metabolites; 2019 Jan; 9(2):. PubMed ID: 30695998
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Gut microbiota, metabolites and host immunity.
    Rooks MG; Garrett WS
    Nat Rev Immunol; 2016 May; 16(6):341-52. PubMed ID: 27231050
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Advances in host-microbe metabolic axis].
    Pi Y; Gao K; Zhu W
    Wei Sheng Wu Xue Bao; 2017 Feb; 57(2):161-9. PubMed ID: 29750478
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Investigation of Host-Gut Microbiota Modulation of Therapeutic Outcome.
    Yip LY; Chan EC
    Drug Metab Dispos; 2015 Oct; 43(10):1619-31. PubMed ID: 25979259
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Integration of microbiome and epigenome to decipher the pathogenesis of autoimmune diseases.
    Chen B; Sun L; Zhang X
    J Autoimmun; 2017 Sep; 83():31-42. PubMed ID: 28342734
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The gut microbiota, obesity and insulin resistance.
    Shen J; Obin MS; Zhao L
    Mol Aspects Med; 2013 Feb; 34(1):39-58. PubMed ID: 23159341
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Symbiotic and antibiotic interactions between gut commensal microbiota and host immune system.
    Malys MK; Campbell L; Malys N
    Medicina (Kaunas); 2015; 51(2):69-75. PubMed ID: 25975874
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Metagenomics and Single-Cell Omics Data Analysis for Human Microbiome Research.
    Han M; Yang P; Zhou H; Li H; Ning K
    Adv Exp Med Biol; 2016; 939():117-137. PubMed ID: 27807746
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Deciphering the human microbiome using next-generation sequencing data and bioinformatics approaches.
    Kim Y; Koh I; Rho M
    Methods; 2015 Jun; 79-80():52-9. PubMed ID: 25448477
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The Mycobiome: Impact on Health and Disease States.
    El-Jurdi N; Ghannoum MA
    Microbiol Spectr; 2017 Jun; 5(3):. PubMed ID: 28597821
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Metagenomics: key to human gut microbiota.
    Maccaferri S; Biagi E; Brigidi P
    Dig Dis; 2011; 29(6):525-30. PubMed ID: 22179207
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.